Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis

Metastasis is an intricate process by which a small number of cancer cells from the primary tumor site undergo numerous alterations, which enables them to form secondary tumors at another and often multiple sites in the host. Transition of a cancer cell from epithelial to mesenchymal phenotype is thought to be the first step in the progression of metastasis. Recently, the recognition of cancer stem cells has added to the perplexity in understanding metastasis, as studies suggest cancer stem cells to be the originators of metastasis. All current and investigative drugs have been unable to prevent or reverse metastasis, as a result of which most metastatic cancers are incurable. A potential drug that can be considered is metformin, an oral hypoglycemic drug. In this review we discuss the potential of metformin in targeting both epithelial to mesenchymal transition and cancer stem cells in combating cancer metastases.

[1]  Lixin Wei,et al.  Epithelial-Mesenchymal Transition in tumor microenvironment , 2011, Cell & Bioscience.

[2]  M. Duncan,et al.  aV integrins and TGF-β-induced EMT: a circle of regulation , 2012, Journal of cellular and molecular medicine.

[3]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[4]  L. Pusztai,et al.  Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial , 2011, Breast Cancer Research and Treatment.

[5]  Qing‐Yu He,et al.  Epidermal growth factor-induced epithelial-mesenchymal transition in human esophageal carcinoma cells--a model for the study of metastasis. , 2010, Cancer letters.

[6]  K. Kimura,et al.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. , 2007, The Journal of clinical investigation.

[7]  H. Pehamberger,et al.  Neoplastic stem cells: current concepts and clinical perspectives. , 2010, Critical reviews in oncology/hematology.

[8]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[9]  K. Phoenix,et al.  Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy , 2010, Breast Cancer Research and Treatment.

[10]  N. Barker,et al.  The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression , 2008, Clinical & Experimental Metastasis.

[11]  B. Martín-Castillo,et al.  The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells , 2011, Breast Cancer Research and Treatment.

[12]  D. Hardie.  AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. , 2011, Genes & development.

[13]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[14]  S. Bhattacharya,et al.  Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. , 2009, Reproductive biomedicine online.

[15]  T. Kourelis,et al.  Metformin and cancer: new applications for an old drug , 2012, Medical Oncology.

[16]  H. Randeva,et al.  Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells. , 2011, The Journal of clinical endocrinology and metabolism.

[17]  A. Ravaud,et al.  The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers. , 2010, Urologic oncology.

[18]  P. Donnan,et al.  New Users of Metformin Are at Low Risk of Incident Cancer , 2009, Diabetes Care.

[19]  I. Ben-Sahra,et al.  The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level , 2008, Oncogene.

[20]  Y. Hwang,et al.  Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase‐9 activation through a calcium and protein kinase Cα‐dependent pathway: phorbol‐12‐myristate‐13‐acetate‐induced/extracellular signal‐regulated kinase/activator protein‐1 , 2010, British journal of pharmacology.

[21]  M. J. van de Vijver,et al.  The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis , 2009, Proceedings of the National Academy of Sciences.

[22]  F. Ovalle.  Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16 , 2010 .

[23]  Funda Meric-Bernstam,et al.  Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  C. Billottet,et al.  Modulation of several waves of gene expression during FGF‐1 induced epithelial‐mesenchymal transition of carcinoma cells , 2008, Journal of cellular biochemistry.

[25]  R. Weinberg,et al.  Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[26]  Dario R Alessi,et al.  Metformin and reduced risk of cancer in diabetic patients , 2005, BMJ : British Medical Journal.

[27]  G. Z. Rocha,et al.  Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth , 2011, Clinical Cancer Research.

[28]  J. Clements,et al.  Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.

[29]  M. Frank,et al.  The therapeutic promise of the cancer stem cell concept. , 2010, The Journal of clinical investigation.

[30]  I. Ben-Sahra,et al.  Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. , 2011, Cancer research.

[31]  Manal M. Hassan,et al.  Antidiabetic therapies affect risk of pancreatic cancer. , 2009, Gastroenterology.

[32]  Kunihiro Hosono,et al.  Metformin suppresses intestinal polyp growth in ApcMin/+ mice , 2008, Cancer science.

[33]  L. Harhaji-Trajković,et al.  Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt. , 2011, European journal of pharmacology.

[34]  M. Post,et al.  Mouse Snail Is a Target Gene for HIF , 2011, Molecular Cancer Research.

[35]  M. Zou,et al.  Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice , 2011, Diabetes.

[36]  G. Gobbel,et al.  Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis , 2005, Laboratory Investigation.

[37]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[38]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[39]  H. Li,et al.  Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells , 2006, Oncogene.

[40]  C. Michiels,et al.  Autophagy as a mediator of chemotherapy-induced cell death in cancer. , 2011, Biochemical pharmacology.

[41]  C. Heldin,et al.  Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.

[42]  A. Yasmeen,et al.  Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins. , 2011, Gynecologic oncology.

[43]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[44]  E. Polley,et al.  AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma , 2011, Proceedings of the National Academy of Sciences.

[45]  K. Chan,et al.  Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations , 2008, Molecular Cancer Research.

[46]  T. Kim,et al.  The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus , 2012, International journal of cancer.

[47]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[49]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[50]  Takashi Aoi,et al.  Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells , 2008, Science.

[51]  A. Cheung,et al.  p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. , 2008, Cancer research.

[52]  G. Hortobagyi,et al.  Effect of metformin on survival outcomes in diabetic patients with triple receptor‐negative breast cancer , 2012, Cancer.

[53]  L. Walsh,et al.  IGF-1 increases invasive potential of MCF 7 breast cancer cells and induces activation of latent TGF-β1 resulting in epithelial to mesenchymal transition , 2011, Cell Communication and Signaling.

[54]  Sungpil Yoon,et al.  A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells , 2012, Investigational New Drugs.

[55]  F. Gao,et al.  Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes , 2011, Cancer.

[56]  L. Witters.  The blooming of the French lilac. , 2001, The Journal of clinical investigation.

[57]  C. Thornton,et al.  The regulation and function of mammalian AMPK‐related kinases , 2009, Acta physiologica.

[58]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[59]  J. Izbicki,et al.  Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer. , 2011, Cancer research.

[60]  T. Yau,et al.  A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. , 2010, Cell stem cell.

[61]  B. Martín-Castillo,et al.  Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis , 2010, Cell cycle.

[62]  R. DePinho,et al.  The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin , 2005, Science.

[63]  I. Kang,et al.  Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. , 2008, Carcinogenesis.

[64]  Thomas Kirchner,et al.  Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.

[65]  A. Tsirigos,et al.  Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer , 2011, Cell cycle.

[66]  Chunxiao Zhou,et al.  Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy. , 2010, Gynecologic oncology.

[67]  D. Radisky,et al.  Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. , 2009, Cancer research.

[68]  Q. Ma,et al.  Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-a-induced epithelial-mesenchymal transition of MCF-7 cells , 2007 .

[69]  M. Fraga,et al.  The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors , 2003, Journal of Cell Science.

[70]  J. Settleman,et al.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.

[71]  Shailendra Giri,et al.  Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner , 2009, Journal of cellular and molecular medicine.

[72]  F. Bertucci,et al.  Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. , 2009, Cancer research.

[73]  R. Bast,et al.  Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer , 2010, Molecular Cancer Therapeutics.

[74]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[75]  A. Rajasekaran,et al.  Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. , 2006, Cancer research.

[76]  Zhiwei Wang,et al.  Platelet‐Derived Growth Factor‐D Overexpression Contributes to Epithelial‐Mesenchymal Transition of PC3 Prostate Cancer Cells , 2008, Stem cells.

[77]  R. Ozaki,et al.  Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus , 2011, Cancer.

[78]  Z. Marković,et al.  Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis , 2007, Cellular and Molecular Life Sciences.

[79]  M. Pollak,et al.  Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth. , 2008, Endocrine-related cancer.

[80]  Alexander Brawanski,et al.  CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. , 2007, Cancer research.

[81]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[82]  Mohamed H. Sayegh,et al.  Identification of cells initiating human melanomas , 2008, Nature.

[83]  L. Berstein.  Metformin, insulin, breast cancer and more... , 2009, Future oncology.

[84]  Lesley A. Mathews,et al.  Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature , 2009, Clinical & Experimental Metastasis.

[85]  S. Rafii,et al.  Preparing the "soil": the premetastatic niche. , 2006, Cancer research.

[86]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[87]  C. Franceschi,et al.  Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice , 2005, Experimental Gerontology.

[88]  D. Balzi,et al.  Sulphonylureas and cancer: a case–control study , 2008, Acta Diabetologica.

[89]  S. Majumdar,et al.  Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin , 2006, Diabetes Care.

[90]  E. Gale,et al.  The influence of glucose-lowering therapies on cancer risk in type 2 diabetes , 2009, Diabetologia.

[91]  S. Jick,et al.  Use of metformin and the risk of ovarian cancer: a case-control analysis. , 2011, Gynecologic oncology.

[92]  Nahum Sonenberg,et al.  Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. , 2006, Cancer research.

[93]  B. Viollet,et al.  Role of AMP-activated protein kinase in autophagy and proteasome function. , 2008, Biochemical and biophysical research communications.

[94]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[95]  Hans Lehrach,et al.  Human Induced Pluripotent Stem Cells Harbor Homoplasmic and Heteroplasmic Mitochondrial DNA Mutations While Maintaining Human Embryonic Stem Cell–like Metabolic Reprogramming , 2011, Stem cells.

[96]  G. Mundy.  The premetastatic niche , 2008 .

[97]  J. Brugge,et al.  Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition , 2005, The Journal of cell biology.

[98]  A. Clayton,et al.  Expression and Functional Significance of HtrA1 Loss in Endometrial Cancer , 2010, Clinical Cancer Research.

[99]  A. K. Corsi,et al.  A “latent niche” mechanism for tumor initiation , 2009, Proceedings of the National Academy of Sciences.

[100]  J. Rehman.  Empowering self-renewal and differentiation: the role of mitochondria in stem cells , 2010, Journal of Molecular Medicine.

[101]  Kevin Struhl,et al.  Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. , 2009, Cancer research.

[102]  X. Bai,et al.  Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft. , 2013, Urologic oncology.

[103]  Patrick W. Lee,et al.  Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis , 2011, Stem cells.

[104]  P. McKeown-Longo,et al.  Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. , 2007, Cancer research.

[105]  T. Taguchi,et al.  Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers , 2009, Clinical Cancer Research.

[106]  R. Memmott,et al.  Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis , 2010, Cancer Prevention Research.

[107]  Weiqin Jiang,et al.  Metformin as an energy restriction mimetic agent for breast cancer prevention , 2011, Journal of carcinogenesis.

[108]  Sendurai A Mani,et al.  The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies , 2009, Journal of Mammary Gland Biology and Neoplasia.

[109]  Mark Shackleton,et al.  Efficient tumour formation by single human melanoma cells , 2008 .

[110]  E. López-Bonet,et al.  The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells. , 2010, Oncology reports.

[111]  Graeme I Murray,et al.  Current and emerging concepts in tumour metastasis , 2010, The Journal of pathology.

[112]  Hirokazu Takahashi,et al.  Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial , 2010, Cancer Prevention Research.

[113]  Laurie E Ailles,et al.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.

[114]  Nahum Sonenberg,et al.  The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase , 2008, Cancer Prevention Research.

[115]  R. Derynck,et al.  TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors , 1994, The Journal of cell biology.

[116]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[117]  Massimiliano Cazzaniga,et al.  Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis , 2010, Cancer Prevention Research.

[118]  A. Ghanate,et al.  Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53‐Mediated Apoptosis and Acquiring a Stem‐Like Phenotype in Ovarian Cancer Cells , 2009, Stem cells.

[119]  Anushka Patel.  Patients with Type 2 Diabetes , 2014 .

[120]  X. Ding,et al.  Prevention of pancreatic cancer induction in hamsters by metformin. , 2001, Gastroenterology.